Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4°C with retention of in vitro functional activity

Transfusion

Volumn 37, Issue 1, 1997, Pages 18-24

  Currie, L M ^a   Harper, J R ^a   Allan, H ^a   Connor, J ^a  

^a LIFECELL CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL GROWTH; BLOOD TRANSFUSION REACTION; CONTROLLED STUDY; CRYOPRESERVATION; HUMAN; HUMAN CELL; SEPSIS; STAPHYLOCOCCUS AUREUS; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION;

EID: 0031026539     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37197176946.x     Document Type: Article

References (32)

1. Lazarus HM, Herzig RH, Warm SE, Fishman DJ. Transfusion experience with platelet concentrates stored for 24 to 72 hours at 22°C. Importance of storage time. Transfusion 1982;22:39-43.
2. Murphy S. Platelet storage for transfusion. Semin Hematol 1985;22:165-77.
3. Chiu EK, Yuen KY, Lie AK, et al. A prospective study of symptomatic bacteremia following platelet transfusion and of its management. Transfusion 1994;34:950-4.
4. Yomtovian R, Lazarus HM, Goodnough LT, et al. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993;33:902-9.
5. Braine HG, Kickler TS, Charache P, et al. Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature. Transfusion 1986;26:391-3.
6. Zaza S, Tokars JI, Yomtovian R, et al. Bacterial contamination of platelets at a university hospital: increased identification due to intensified surveillance. Infect Control Hosp Epidemiol 1994;15:82-7.
7. Heal JM, Singal S, Sardisco E, Mayer T. Bacterial proliferation in platelet concentrates. Transfusion 1986;26:388-90.
8. Wagner SJ, Robinette D, Nazario M, Moroff G. Bacteria levels in components prepared from deliberately inoculated whole blood held for 8 or 24 hours at 20 to 24°C. Transfusion 1995;35:911-6.
9. Alvarez FE, Rogge KJ, Tarrand J, Lichtiger B. Bacterial contamination of cellular blood components. A retrospective review at a large cancer center. Ann Clin Lab Sci 1995;25:283-90.
10. Goldman M, Blajchman MA. Blood product-associated bacterial sepsis. Transfus Med Rev 1991;5:73-83.
11. Morduchowicz G, Pitlik SD, Huminer D, et al. Transfusion reactions due to bacterial contamination of blood and blood products. Rev Infect Dis 1991;13:307-14.
12. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990;30:583-90.
13. Morrow JF, Braine HG, Kickler TS, et al. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991;266:555-8.
14. Heddle NM, Klama L, Singer J, et al.The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
15. Davenport RD, Kunkel SL. Cytokine roles in hemolytic and non-hemolytic transfusion reactions. Transfus Med Rev 1994;8:157-68.
16. Muylle L, Joos M, Wouters E, et al. Increased tumor necrosis factor α (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-9.
17. Stack G, Synder EL. Cytokine generation in stored platelet concentrates. Transfusion 1994;34:20-5.
18. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117-24.
19. Muylle L, Wouters E, De Bock R, Peetermans ME. Reactions to platelet transfusion: the effect of the storage time of the concentrate. Transfus Med 1992;2:289-93.
20. Sweeney JD, Holme S, Stromberg RR, Heaton WA. In vitro and in vivo effects of prestorage filtration of apheresis platelets. Transfusion 1995;35:125-30.
21. Sweeney JD, Holme S, Heaton WA, Nelson E. White cell-reduced platelet concentrates prepared by in-line filtration of platelet-rich plasma. Transfusion 1995;35:131-6.
22. Muylle L, Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994;66:14-7.
23. Flegel WA, Wiesneth M, Stampe D, Koerner K. Low cytokine contamination in buffy coat-derived platelet concentrates without filtration. Transfusion 1995;35:917-20.
24. Buchholz DH, AuBuchon JP, Snyder EL, et al. Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion 1994;34:852-7.
25. Connor J, Currie LM, Allan H, Livesey SA. Recovery of in vitro functional activity of platelet concentrates stored at 4°C and treated with second-messenger effectors. Transfusion 1996;36:691-8.
26. Walker RH, ed. Technical manual. 11th ed. Bethesda: American Association of Blood Banks, 1993:730-1.
27. White JG, Krivit W. An ultrastructural basis for the shape changes induced in platelets by chilling. Blood 1967;30:625-35.
28. Handin RI, Fortier NL, Valeri CR. Platelet response to hypotonic stress after storage at 4 C or 22 C. Transfusion 1970;10:305-9.
29. Watts SE, Tunbridge LJ, Smith K, Lloyd JV. Storage of platelets for tests of platelet function: effects of temperature on platelet aggregation, platelet morphology and liberation of β-thromboglobulin. Thromb Res 1986;44;365-76.
30. Slichter SJ, Harker LA. Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. Br J Haematol 1976;34:403-19.
31. Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994;7:290-302.
32. Gong J, Högman CF, Hambraeus A, et al. Transfusion-transmitted Yersinia enterocolitica infection. Protection through buffy coat removal and failure of the bacteria to grow in platelet-rich or platelet-poor plasma. Vox Sang 1993;65:42-6.